OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,140,244 | +91.3% | 1,873,704 | +39.9% | 2.54% | +203.6% |
Q2 2023 | $12,093,617 | +106.3% | 1,339,271 | -20.7% | 0.84% | +105.2% |
Q1 2023 | $5,862,617 | +141543.3% | 1,689,515 | 0.0% | 0.41% | -14.7% |
Q4 2022 | $4,139 | -99.9% | 1,689,515 | 0.0% | 0.48% | -7.4% |
Q3 2022 | $4,663,000 | -32.2% | 1,689,515 | 0.0% | 0.52% | -25.4% |
Q2 2022 | $6,876,000 | -4.5% | 1,689,515 | 0.0% | 0.69% | +39.1% |
Q1 2022 | $7,197,000 | -54.5% | 1,689,515 | 0.0% | 0.50% | -48.0% |
Q4 2021 | $15,814,000 | -53.7% | 1,689,515 | +36.4% | 0.95% | -37.8% |
Q3 2021 | $34,135,000 | -1.5% | 1,238,575 | 0.0% | 1.53% | +2.2% |
Q2 2021 | $34,655,000 | -15.7% | 1,238,575 | 0.0% | 1.50% | +3.9% |
Q1 2021 | $41,096,000 | -31.0% | 1,238,575 | 0.0% | 1.44% | -45.7% |
Q4 2020 | $59,551,000 | – | 1,238,575 | – | 2.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |